Medical Science
| Open Access |
DOI: Key Aspects Of The Safe Use Of Nonsteroidal Anti-Inflammatory Drugs In Children
Mukhitdinova Mavdjuda Imadovna , Candidate of Medical Sciences, Associate Professor of the Department of Family Medicine No. 2, Clinical Pharmacology, Tashkent State Medical University, UzbekistanAbstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) occupy an important place in pediatric practice due to their pronounced analgesic, antipyretic, and anti-inflammatory effects. However, their use in children requires particular caution due to age-related differences in pharmacokinetics and pharmacodynamics, immature detoxification systems, and increased sensitivity to side effects. The aim of this article is to comprehensively analyze key aspects of the safe use of NSAIDs in children, including indications, dosage, potential risks, drug interactions, and current approaches to minimizing adverse reactions. This paper summarizes clinical observation data, the results of modern research, and international guidelines, allowing for the formulation of practical conclusions for clinicians. Particular attention is paid to issues of gastrointestinal, nephrotoxic, and cardiovascular safety, as well as the rational choice of drug based on age and clinical situation.
Keywords
Nonsteroidal anti-inflammatory drugs, pediatrics, drug safety
References
Baranov A.A. Pediatrics: national guidelines. - M.: GEOTAR-Media, 2022.
Kharkevich D.A. Pharmacology. - M.: GEOTAR-Media, 2021.
Samsygina G.A., Mazankova L.N. Clinical pharmacology in pediatrics. - M.: Medicine, 2020.
Vertkin A.L. Nonsteroidal anti-inflammatory drugs: effectiveness and safety. — M.: Practical Medicine, 2019.
Zaplatnikov A.L. Safety of drug therapy in children. - St. Petersburg: SpetsLit, 2021.
Namazova-Baranova L.S. Modern approaches to the treatment of fever in children // Pediatrics. - 2020. - No. 4. — P. 6–12.
World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children. — Geneva, 2018.
British National Formulary for Children. — London: BMJ Group, 2022.
European Medicines Agency. Assessment report on NSAIDs use in pediatrics. — EMA, 2021.
Anderson B.J. Pediatric pharmacology and drug safety // Pediatric Anesthesia. — 2020. — Vol. 30. — P. 22–29.
Kearns G.L. et al. Developmental pharmacology — drug disposition, action, and therapy in infants and children // New England Journal of Medicine. — 2019. — Vol. 381. — P. 165–175.
Southey E.R., Soares-Weiser K., Kleijnen J. Systematic review and meta-analysis of the clinical safety of ibuprofen in children // Pediatrics. — 2020. — Vol. 145.
Standing J.F., Tuleu C. Paediatric formulations — getting to the heart of the problem // International Journal of Pharmaceutics. — 2018. — Vol. 536. — P. 441–449.
FDA. Use of NSAIDs in pediatric populations: safety communication. — U.S. Food and Drug Administration, 2021.
Download and View Statistics
Copyright License
Copyright (c) 2026 Mukhitdinova Mavdjuda Imadovna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.